You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer

Citation Tools

Article menu

Download PDFPDF

Research Article
A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Engel-Riedel W, Lowe J, Mattson P, et al
A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer
Journal for ImmunoTherapy of Cancer 2018;6:16. doi: 10.1186/s40425-018-0324-z